Summerset spent more in pandemic but revaluations strong
Revaluations of $221.1m boosted bottom-line result
AdvertisementAdvertise with NZME.
Latest fromRetirement Villages
Ryman Healthcare staff offered saliva testing
Rest home staff helping to discover the effectiveness of saliva tests to detect Covid-19.
The 45,000 vulnerable residents living under the strictest conditions in NZ
These are the residents living under the strictest conditions in the country.
No jab, no job: The company where all new staff need Covid vaccine
Those wanting to get a job with Arvida must agree to have a Covid vaccination.
Consumer NZ critical of retirement village regulations
Some contracts risk breaching consumer law says chief executive.
Simon Wallace: Critical junction for aged care
Opinion: Sector is underfunded by an estimated $425 million per year but keeps delivering.
Arvida sales up 29 per cent after Covid lockdowns
Illness, need for a higher level of care or death - reasons for village resales
'Overlooked': Kiwi company's shares surge 300 per cent in 10 months
Share price rise expected to continue, with its fortunes partly pegged to housing sector.
Retirement giant clocks 31% quarterly sales boost
Illness or death of residents not main reason for strong trade
Retirement village owner to repay $8.6m wage subsidy
Outgoing chairman Rob Campbell said the time was right to return the money.
Rare event: NZX listing for Radius
176m fully-allocated shares listed at 80c, giving $141m valuation.
New aged care/retirement village owner to list on NZX
"I can't wait to ring that bell on listing" - Brien Cree
Retirement village law overhaul mooted
The sector lacks a simple complaints system, the paper says.
What the pandemic cost Ryman Healthcare
Company bought four Alpaure AP4 sterilising fog machines for $1m - MacLeod.
Ryman spends $50m on pandemic response
First half-year results out for NZ's biggest listed retirement business
Retirement business to repay $6.8 million wage subsidy
"In spirit of scheme to return subsidy" - EQT's Ken Wong
$600m retirement village plans rile neighbours
So why doesn't the Unitary Plan bar such large schemes beside smaller homes?
$100m sale of Caughey land will help needy Kiwis
Sale of Remuera rest home frees up Caughey Preston Trust to change direction.
Business Hub: Te Ao Māori values govern 'world-first' Tahito fund
"As soon as you do this, you become the kaitiaki of these values." - Temuera Hall.
'Milestone' day as $1.2b Metlifecare delists tonight
Glen Sowry thanked the board and shareholders 'for their service and support'.
Neighbours take on Ryman over $150m plan
Residents worry about buildings' height, barrister says developers 'not the bad guys'.
Investor in Metlifecare tries to block $1.27b deal
Company 'considering notice of opposition'
What next for Metlifecare after $1.27b takeover?
Super Fund expresses satisfaction with result.
$130 million development begins on volcanic crater rim
This is one of the biggest projects on the books for Oceania Healthcare.
Metlifecare shareholders approve $1.27b takeover
Hard questions put to board over controversial takeover offer.
Fund manager opposes $1.27b Metlifecare takeover
"Discount relative to its peers excessive" - Matthew Goodson.
NZ Super Fund to quit Metlifecare at $6 a share
Fund backs majority of directors, in favour of share price offer.
Shareholders Association questions Metlifecare board, NZ Super Fund over deal
NZSA to vote against takeover deal
Ryman's plans for $150m retirement village in Auckland: Submissions called
Auckland Council is calling for submissions on the scheme.
Swedish group step closer in bid to buy Metlifecare
Some still smarting about the lower offer as house prices improve
Metlifecare chairman to vote against $1.27b takeover
No opportunity for board to use litigation to push up offer price, Kim Ellis says.
Covid-19 coronavirus: The 'new normal' of visiting New Zealand aged care facilities
Retirement village operators and Aged Care Association are calling for patience.
Valuers' Covid caution drives Metlifecare to record net loss
Values hit hard by Covid's effects